These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16458316)

  • 1. Accumulation of chylomicron remnants and impaired vascular reactivity occur in subjects with isolated low HDL cholesterol: effects of niacin treatment.
    Benjó AM; Maranhão RC; Coimbra SR; Andrade AC; Favarato D; Molina MS; Brandizzi LI; da Luz PL
    Atherosclerosis; 2006 Jul; 187(1):116-22. PubMed ID: 16458316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins.
    Sposito AC; Santos RD; Amâncio RF; Ramires JA; Chapman MJ; Maranhão RC
    Atherosclerosis; 2003 Feb; 166(2):311-21. PubMed ID: 12535744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons.
    Wajchenberg BL; Amâncio RF; Santomauro AT; Maranhão RC
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):347-52. PubMed ID: 15355451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of chylomicron-like emulsions in carriers of the S447X lipoprotein lipase polymorphism.
    Almeida KA; Schreiber R; Amâncio RF; Bydlowski SP; Debes-Bravo A; Issa JS; Strunz CM; Maranhão RC
    Clin Chim Acta; 2003 Sep; 335(1-2):157-63. PubMed ID: 12927697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed intravascular catabolism of chylomicron-like emulsions is an independent predictor of coronary artery disease.
    Sposito AC; Ventura LI; Vinagre CG; Lemos PA; Quintella E; Santos RD; Carneiro O; Ramires JA; Maranhão RC
    Atherosclerosis; 2004 Oct; 176(2):397-403. PubMed ID: 15380465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study.
    Warnholtz A; Wild P; Ostad MA; Elsner V; Stieber F; Schinzel R; Walter U; Peetz D; Lackner K; Blankenberg S; Munzel T
    Atherosclerosis; 2009 May; 204(1):216-21. PubMed ID: 18822413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chylomicron metabolism is markedly altered in systemic lupus erythematosus.
    Borba EF; Bonfá E; Vinagre CG; Ramires JA; Maranhão RC
    Arthritis Rheum; 2000 May; 43(5):1033-40. PubMed ID: 10817556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis.
    van Wijk JP; Buirma R; van Tol A; Halkes CJ; De Jaegere PP; Plokker HW; van der Helm YJ; Castro Cabezas M
    Atherosclerosis; 2005 Jan; 178(1):147-55. PubMed ID: 15585212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?
    Ng TW; Watts GF; Stuckey BG; Ching HL; Chan DC; Uchida Y; Sakai N; Yamashita S; Martins IJ; Redgrave TG; Barrett PH
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):650-6. PubMed ID: 16343099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of gemfibrozil upon the metabolism of chylomicron-like emulsions in patients with endogenous hypertriglyceridemia.
    Santos RD; Ventura LI; Spósito AC; Schreiber R; Ramires JA; Maranhão RC
    Cardiovasc Res; 2001 Feb; 49(2):456-65. PubMed ID: 11164856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects.
    Mangili OC; Moron Gagliardi AC; Mangili LC; Mesquita CH; Machado Cesar LA; Tanaka A; Schaefer EJ; Maranhão RC; Santos RD
    Atherosclerosis; 2014 Mar; 233(1):319-25. PubMed ID: 24503114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation.
    Dubé MP; Komarow L; Fichtenbaum CJ; Cadden JJ; Overton ET; Hodis HN; Currier JS; Stein JH;
    Clin Infect Dis; 2015 Sep; 61(5):840-9. PubMed ID: 25979307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of gemfibrozil +/- niacin +/- cholestyramine on endothelial function in patients with serum low-density lipoprotein cholesterol levels <160 mg/dl and high-density lipoprotein cholesterol levels <40 mg/dl.
    Andrews TC; Whitney EJ; Green G; Kalenian R; Personius BE
    Am J Cardiol; 1997 Oct; 80(7):831-5. PubMed ID: 9381993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease.
    Maranhão RC; Feres MC; Martins MT; Mesquita CH; Toffoletto O; Vinagre CG; Gianinni SD; Pileggi F
    Atherosclerosis; 1996 Sep; 126(1):15-25. PubMed ID: 8879430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of extended-release niacin on lipid profile and adipocyte biology in patients with impaired glucose tolerance.
    Linke A; Sonnabend M; Fasshauer M; Höllriegel R; Schuler G; Niebauer J; Stumvoll M; Blüher M
    Atherosclerosis; 2009 Jul; 205(1):207-13. PubMed ID: 19131065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of triglyceride-rich lipoproteins and transfer of lipids to high-density lipoproteins (HDL) in vegan and omnivore subjects.
    Vinagre JC; Vinagre CG; Pozzi FS; Slywitch E; Maranhão RC
    Nutr Metab Cardiovasc Dis; 2013 Jan; 23(1):61-7. PubMed ID: 21937206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term effects of extended-release niacin on endothelial function in HIV-infected patients on stable antiretroviral therapy.
    Chow DC; Stein JH; Seto TB; Mitchell C; Sriratanaviriyakul N; Grandinetti A; Gerschenson M; Shiramizu B; Souza S; Shikuma C
    AIDS; 2010 Apr; 24(7):1019-23. PubMed ID: 20216298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment: a long-term follow-up study.
    Sposito AC; Lemos PA; Santos RD; Hueb W; Vinagre CG; Quintella E; Carneiro O; Chapman MJ; Ramires JA; Maranhão RC
    J Am Coll Cardiol; 2004 Jun; 43(12):2225-32. PubMed ID: 15193684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships in women between body mass index and the intravascular metabolism of chylomicron-like emulsions.
    Oliveira MR; Maranhão RC
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1471-8. PubMed ID: 15486570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.